Skip to main content

Table 2 Patient pre-therapy characteristics and treatment details

From: Focal therapy using magnetic resonance image-guided focused ultrasound in patients with localized prostate cancer

  Patient 1 Patient 2 Patient 3
Age 64 60 61
BMI 26.5 25.4 23.9
Prostate volume (ml) 45.6 51 21
Gleason score 3 + 3 3 + 3 3 + 3
Clinical stage T1c T1c T1c
Pre-therapy PSA (ng/ml) 1.96 4.13 2.14
Previous therapy None None Leuprolide 3-month duration (stopped 6 months prior to protocol entry)
Pre-therapy multiparametric MRI and CT No visible lesion No visible lesion No visible lesion
Sectors positive on biopsy pre-therapy (% and length of core) Right posterior lateral base (2 %, 0.2 mm)
Left lateral base (5 %, 0.5 mm)
Left anterior lateral apex (1 %, 0.2 mm)
Left anterior medial apex (1 %, 0.5 mm)
Left posterior lateral apex (10 %, 5 mm)
Left anterior medial apex (10 %, 2 mm)
Left posterior lateral apex (5 %, 1 mm)
Left posterior medial apex (20 %, 2.5 mm)
Left posterior medial base (10 %, 2 mm)
Number of treatment (macro) sonications 11 6 12
Total sonication time 3 h 55 min 1 h 3 min 1 h 46 min
Total time in scanner 6 h 18 min 3 h 34 min 3 h 40 min
Pain score postoperatively 0–1 0–1 0–1